Literature DB >> 28277858

Pathophysiology of dyspnea in COPD.

Antonio Anzueto1,2, Marc Miravitlles3,4.   

Abstract

Dyspnea refers to the sensation of breathlessness, shortness of breath, or difficulty breathing that is commonly observed in patients with respiratory and cardiac disease. In the United States alone, dyspnea is reported in up to 4 million all-cause emergency room visits annually. Dyspnea can be a symptom of several different underlying physical conditions, typically involving the lung and heart. Indeed, it is an important symptom in chronic obstructive pulmonary disease (COPD), where it is associated with limited physical activity, increased anxiety and depression, decreased health-related quality of life (HRQoL), and reduced survival. Currently there is no single physiological correlate that will accurately predict dyspnea, particularly because the mechanisms that contribute to respiratory discomfort can vary between diseases and between individuals experiencing breathlessness who have been diagnosed with the same disease. Therefore, various subjective clinical and psychophysical scales and questionnaires are typically used to measure or predict dyspnea. It is the goal of this review to discuss the pathophysiological mechanisms leading to dyspnea, particularly those associated with COPD, the physical and psychological impact on patients, assessment approaches, and modalities currently used to treat it.

Entities:  

Keywords:  COPD; bronchodilator; dyspnea; lung

Mesh:

Substances:

Year:  2017        PMID: 28277858     DOI: 10.1080/00325481.2017.1301190

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  13 in total

Review 1.  Biofabrication of phenotypic pulmonary fibrosis assays.

Authors:  Cameron Yamanishi; Stephen Robinson; Shuichi Takayama
Journal:  Biofabrication       Date:  2019-06-19       Impact factor: 9.954

2.  Profile of Cardiovascular Disease Patients Who are Diagnosed with COPD in a Smoking-Cessation Unit.

Authors:  Juan A Riesco; María Hidalgo; David Chipayo; José J Gómez; Fernando Zaragozá
Journal:  Adv Ther       Date:  2020-06-13       Impact factor: 3.845

Review 3.  Tiotropium in chronic obstructive pulmonary disease - a review of clinical development.

Authors:  Antonio Anzueto; Marc Miravitlles
Journal:  Respir Res       Date:  2020-07-29

Review 4.  Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions.

Authors:  Nicola A Hanania; Denis E O'Donnell
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-05-24

5.  Terminological Usage Related to Dyspnea by Nursing Staff: A Cross-Sectional Questionnaire Survey.

Authors:  Yuko Nemoto; Sayuri Suzuki; Shinichiro Okauchi; Katsunori Kagohashi; Hiroaki Satoh
Journal:  Asian Pac Isl Nurs J       Date:  2020

6.  Poor Work Efficiency is Associated with Poor Exercise Capacity and Health-Related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Shih-Hsing Yang; Mei-Chen Yang; Yao-Kuang Wu; Chih-Wei Wu; Po-Chun Hsieh; Chan-Yen Kuo; I-Shiang Tzeng; Chou-Chin Lan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-02-10

Review 7.  What have we learned from observational studies and clinical trials of mild to moderate COPD?

Authors:  Miriam Barrecheguren; Cruz González; Marc Miravitlles
Journal:  Respir Res       Date:  2018-09-17

8.  Prevalence and correlates of obstructive lung disease among people who inject drugs, San Diego, California.

Authors:  Hayley J Koslik; Jisha Joshua; Jazmine Cuevas-Mota; Daniel Goba; Eyal Oren; John E Alcaraz; Richard S Garfein
Journal:  Drug Alcohol Depend       Date:  2020-07-02       Impact factor: 4.492

9.  Acceptance and Potential Impact of the eWALL Platform for Health Monitoring and Promotion in Persons with a Chronic Disease or Age-Related Impairment.

Authors:  Francesco Infarinato; Stephanie Jansen-Kosterink; Paola Romano; Lex van Velsen; Harm Op den Akker; Federica Rizza; Marco Ottaviani; Sofoklis Kyriazakos; Beatrix Wais-Zechmann; Markus Garschall; Stefano Bonassi; Hermie J Hermens
Journal:  Int J Environ Res Public Health       Date:  2020-10-28       Impact factor: 3.390

10.  Relationship Between Clinical Control, Respiratory Symptoms and Quality of Life for Patients with COPD.

Authors:  Bernardino Alcazar-Navarrete; Antonia Fuster; Patricia García Sidro; Juan Luis García Rivero; Beatriz Abascal-Bolado; Abel Pallarés-Sanmartín; Eduardo Márquez; Agustin Valido-Morales; Ana Boldova Loscertales; Francisco Javier Callejas-Gonzalez; Marta Palop; Juan Antonio Riesco; Rafael Golpe; Juan Jose Soler-Cataluña; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.